{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:48Z","timestamp":1790168448625,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of China","award":["825B2022"],"award-info":[{"award-number":["825B2022"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370862"],"award-info":[{"award-number":["82370862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Innovation 2030","award":["2023ZD0508402"],"award-info":[{"award-number":["2023ZD0508402"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03010-4","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:42:13Z","timestamp":1783006933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline self-reported supplement category use and two-visit difference in lipoprotein(a): an observational analysis in UK Biobank"],"prefix":"10.1186","volume":"25","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9591-6991","authenticated-orcid":false,"given":"Ningjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"3010_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.2530631","volume":"246","author":"G Utermann","year":"1989","unstructured":"Utermann G. The mysteries of lipoprotein(a). Science. 1989;246:904\u201310.","journal-title":"Science"},{"key":"3010_CR2","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43:3925\u201346.","journal-title":"Eur Heart J"},{"key":"3010_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/10408363.2023.2229915","volume":"60","author":"SM Marcovina","year":"2023","unstructured":"Marcovina SM. Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease. Crit Rev Clin Lab Sci. 2023;60:560\u201372.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3010_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302:412\u201323.","journal-title":"JAMA"},{"key":"3010_CR5","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1038\/s41467-018-04668-w","volume":"9","author":"SM Zekavat","year":"2018","unstructured":"Zekavat SM, Ruotsalainen S, Handsaker RE, Alver M, Bloom J, Poterba T, Seed C, Ernst J, Chaffin M, Engreitz J, et al. Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. Nat Commun. 2018;9:2606.","journal-title":"Nat Commun"},{"key":"3010_CR6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/00005768-199711000-00007","volume":"29","author":"LT Mackinnon","year":"1997","unstructured":"Mackinnon LT, Hubinger L, Lepre F. Effects of physical activity and diet on lipoprotein(a). Med Sci Sports Exerc. 1997;29:1429\u201336.","journal-title":"Med Sci Sports Exerc"},{"key":"3010_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2014.01.049","volume":"234","author":"A Langsted","year":"2014","unstructured":"Langsted A, Kamstrup PR, Nordestgaard BG. Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk. Atherosclerosis. 2014;234:95\u2013101.","journal-title":"Atherosclerosis"},{"key":"3010_CR8","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361:2518\u201328.","journal-title":"N Engl J Med"},{"key":"3010_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/eurheartj\/ehae652","volume":"46","author":"J Ghouse","year":"2025","unstructured":"Ghouse J, Ahlberg G, Albertsen Rand S, Salling Olesen M, Vilhjalmsson B, Stender S, Bundgaard H. Within-person stability of lipoprotein(a) concentration. Eur Heart J. 2025;46:1159\u201361.","journal-title":"Eur Heart J"},{"key":"3010_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","volume":"382","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, Baum SJ, Steinhagen-Thiessen E, Shapiro MD, Stroes ES, Moriarty PM, Nordestgaard BG, et al. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. N Engl J Med. 2020;382:244\u201355.","journal-title":"N Engl J Med"},{"key":"3010_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ahj.2015.03.004","volume":"169","author":"DJ Kereiakes","year":"2015","unstructured":"Kereiakes DJ, Robinson JG, Cannon CP, Lorenzato C, Pordy R, Chaudhari U, Colhoun HM. Efficacy and safety of the proprotein convertase subtilisin\/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study. Am Heart J. 2015;169:906\u2013e915913.","journal-title":"Am Heart J"},{"key":"3010_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","volume":"139","author":"ML O\u2019Donoghue","year":"2019","unstructured":"O\u2019Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, \u010ce\u0161ka R, et al. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk. Circulation. 2019;139:1483\u201392.","journal-title":"Circulation"},{"key":"3010_CR13","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844\u201353.","journal-title":"Eur Heart J"},{"key":"3010_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/jama.2016.14403","volume":"316","author":"ED Kantor","year":"2016","unstructured":"Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in Dietary Supplement Use Among US Adults From 1999\u20132012. JAMA. 2016;316:1464\u201374.","journal-title":"JAMA"},{"key":"3010_CR15","doi-asserted-by":"publisher","first-page":"106647","DOI":"10.1016\/j.phrs.2023.106647","volume":"188","author":"J Xia","year":"2023","unstructured":"Xia J, Yu J, Xu H, Zhou Y, Li H, Yin S, Xu D, Wang Y, Xia H, Liao W, et al. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol Res. 2023;188:106647.","journal-title":"Pharmacol Res"},{"key":"3010_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S1050-1738(01)00080-9","volume":"11","author":"JL Barth","year":"2001","unstructured":"Barth JL, Argraves WS. Cubilin and megalin: partners in lipoprotein and vitamin metabolism. Trends Cardiovasc Med. 2001;11:26\u201331.","journal-title":"Trends Cardiovasc Med"},{"key":"3010_CR17","doi-asserted-by":"publisher","unstructured":"Li X, Liu Y, Wang J, Chen X, Reichetzeder C, Elitok S, Kr\u00e4mer BK, Doebis C, Huesker K, von Baehr V, Hocher B. Vitamin D Is Associated with Lipid Metabolism: A Sex- and Age-Dependent Analysis of a Large Outpatient Cohort. Nutrients 2024;16. https:\/\/doi.org\/10.3390\/nu16223936.","DOI":"10.3390\/nu16223936"},{"key":"3010_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.plipres.2011.05.001","volume":"50","author":"R Jorde","year":"2011","unstructured":"Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011;50:303\u201312.","journal-title":"Prog Lipid Res"},{"key":"3010_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jacl.2018.03.079","volume":"12","author":"V Schwetz","year":"2018","unstructured":"Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Gr\u00fcbler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, et al. Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial. J Clin Lipidol. 2018;12:588\u2013e596584.","journal-title":"J Clin Lipidol"},{"key":"3010_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/07315724.2013.767659","volume":"32","author":"S Heravifard","year":"2013","unstructured":"Heravifard S, Neyestani TR, Nikooyeh B, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Zahedirad M, Tayebinejad N, Salekzamani S, et al. Regular consumption of both vitamin D- and calcium- and vitamin D-fortified yogurt drink is equally accompanied by lowered blood lipoprotein (a) and elevated apoprotein A1 in subjects with type 2 diabetes: a randomized clinical trial. J Am Coll Nutr. 2013;32:26\u201330.","journal-title":"J Am Coll Nutr"},{"key":"3010_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1024\/0300-9831\/a000709","volume":"93","author":"EJ Brandt","year":"2023","unstructured":"Brandt EJ, Brandt DJ, Desai NR, Spatz ES, Nasir K, Mani A. Association of vitamins, minerals, and lead with lipoprotein(a) in a cross-sectional cohort of US adults. Int J Vitam Nutr Res. 2023;93:99\u2013110.","journal-title":"Int J Vitam Nutr Res"},{"key":"3010_CR22","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"3010_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1213\/ANE.0000000000005593","volume":"133","author":"EO Bayman","year":"2021","unstructured":"Bayman EO, Dexter F. Multicollinearity in Logistic Regression Models. Anesth Analg. 2021;133:362\u20135.","journal-title":"Anesth Analg"},{"key":"3010_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.14309\/ajg.0000000000002180","volume":"118","author":"Y Sun","year":"2023","unstructured":"Sun Y, Yuan S, Chen X, Sun J, Kalla R, Yu L, Wang L, Zhou X, Kong X, Hesketh T, et al. The Contribution of Genetic Risk and Lifestyle Factors in the Development of Adult-Onset Inflammatory Bowel Disease: A Prospective Cohort Study. Am J Gastroenterol. 2023;118:511\u201322.","journal-title":"Am J Gastroenterol"},{"key":"3010_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O\u2019Connell J, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"3010_CR26","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1194\/jlr.M076232","volume":"58","author":"S Mack","year":"2017","unstructured":"Mack S, Coassin S, Rueedi R, Yousri NA, Sepp\u00e4l\u00e4 I, Gieger C, Sch\u00f6nherr S, Forer L, Erhart G, Marques-Vidal P, et al. A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms. J Lipid Res. 2017;58:1834\u201344.","journal-title":"J Lipid Res"},{"key":"3010_CR27","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1210\/jc.2018-00472","volume":"103","author":"N Wang","year":"2018","unstructured":"Wang N, Lu M, Chen C, Xia F, Han B, Li Q, Cheng J, Chen Y, Zhu C, Jensen MD, Lu Y. Adiposity Genetic Risk Score Modifies the Association Between Blood Lead Level and Body Mass Index. J Clin Endocrinol Metab. 2018;103:4005\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"3010_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/atm.2016.10.67","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med. 2016;4:30.","journal-title":"Ann Transl Med"},{"key":"3010_CR29","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","volume":"323","author":"AJ Vickers","year":"2001","unstructured":"Vickers AJ, Altman DG. Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123\u20134.","journal-title":"BMJ"},{"key":"3010_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/0962280210395740","volume":"22","author":"SR Seaman","year":"2013","unstructured":"Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22:278\u201395.","journal-title":"Stat Methods Med Res"},{"key":"3010_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558\u201369.","journal-title":"Korean J Anesthesiol"},{"key":"3010_CR32","doi-asserted-by":"publisher","unstructured":"Fogacci F, Di Micoli V, Sabouret P, Giovannini M, Cicero AFG. Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense? J Clin Med. 2024;13. https:\/\/doi.org\/10.3390\/jcm13030751.","DOI":"10.3390\/jcm13030751"},{"key":"3010_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-2891-13-14","volume":"13","author":"A Dickinson","year":"2014","unstructured":"Dickinson A, MacKay D. Health habits and other characteristics of dietary supplement users: a review. Nutr J. 2014;13:14.","journal-title":"Nutr J"},{"key":"3010_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2005","unstructured":"Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005;34:215\u201320.","journal-title":"Int J Epidemiol"},{"key":"3010_CR35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584\u201391.","journal-title":"Nat Genet"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03010-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:44Z","timestamp":1790164964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-03010-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3010"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03010-4","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles outlined in the Declaration of Helsinki. The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (REC reference 11\/NW\/0382), and all participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"198"}}